Cannara Biotech Inc. achieved a major milestone. It secured the number one market share position in Quebec. This happened in overall cannabis retail sales for December 2025. The company also saw tremendous success. This came from its recent vape cartridge category launch. Estimated retail sales data confirms this success.
Quebec Embraces New Cannabis Vapes
The province of Quebec officially allowed cannabis vape sales. This happened in late 2025. It was a significant policy shift. Before this, vape products were mostly from the unregulated market. Many Quebec consumers already sought these products. They sourced them illicitly or from out-of-province. The Société Québécoise du Cannabis (SQDC) aimed to provide safer options. The vape category launch began in November 2025. This opened a new market for licensed producers.
Cannara’s Strategic Vape Entry
Cannara Biotech was well-prepared for this launch. The company received preliminary approval. This was for five vape cartridge products. These included premium live resin and live rosin formulations. Cannara’s R&D team developed these products. They complied with Quebec’s strict regulations. These rules include a sub-30% THC limit. There are also no added distillates or fillers. Cannara’s live resin vapes were already Canada’s top-selling premium brand. Their five SKUs represented 20% of the 25 authorized vape products at launch. This strategic entry allowed Cannara to capture significant market share quickly.
Dominating the Market
Cannara’s launch strategy paid off handsomely. The company achieved a remarkable 29.7% share. This was within Quebec’s new vape cartridge category. This data covers sales for November and December 2025. This performance propelled Cannara forward. It secured them the #1 market share position in Quebec. This was for overall cannabis retail sales in December 2025. Their share reached 14.7%. This marked a 100-basis point increase from November 2025. This success highlights Cannara’s strong brand appeal. It also shows their ability to meet consumer demand. This rapid market capture demonstrates effective execution.
The Power of Vertical Integration
Cannara credits its success to its advanced, vertically integrated platform. The company operates two large mega facilities in Quebec. These facilities span over 1.65 million square feet. This integration allows for quality control. It covers the entire process from seed to final packaging. This model enables the creation of premium products. It also ensures efficient production. Leveraging Quebec’s lower electricity costs is another advantage. This helps maintain affordable prices. The company’s flagship brands, Tribal, Nugz, and Orchid CBD, benefit from this. The Tribal brand is particularly associated with their successful vape launches.
Future Outlook
Cannara Biotech’s performance in Quebec is a strong indicator. It signals their leadership in Canada’s cannabis industry. The successful new cannabis products in the vape category are a key driver. This achievement positions Cannara for continued growth. The company’s focus on quality and innovation remains a priority. Their strategic market entries are proving highly effective. This momentum is expected to carry forward.
